DGAP-News: PAION AG: ANNUAL GENERAL MEETING ELECTS DR HARALD F. STOCK TO THE SUPERVISORY BOARD
(firmenpresse) - DGAP-News: PAION AG / Key word(s): AGM/EGM
PAION AG: ANNUAL GENERAL MEETING ELECTS DR HARALD F. STOCK TO THE
SUPERVISORY BOARD
24.05.2011 / 15:29
---------------------------------------------------------------------
PAION AG: ANNUAL GENERAL MEETING ELECTS DR HARALD F. STOCK TO THE
SUPERVISORY BOARD
SUCCESSOR TO DR WALTER WENNINGER
Aachen (Germany), 24 May 2011 - The biopharmaceutical company PAION AG
(ISIN DE000A0B65S3; Frankfurt Stock Exchange, Prime Standard: PA8)
announces today that Dr Harald F. Stock has been elected to the company's
Supervisory Board by the Annual General Meeting on 24 May 2011. He replaces
Dr Walter Wenninger who has relinquished his seat with effect from today.
Further members of the board are Dr Jörg Spiekerkötter (chairman) and Alan
Goodman.
In addition, the resolutions proposed by the Management Board and
Supervisory Board were accepted by the Annual General Meeting with large
majorities. The results are available on the company's website
www.paion.com/hv.
In its constituent meeting, the Supervisory Board of PAION appointed Dr
Harald F. Stock to its vice chairman.
The chairman of the Supervisory Board Dr Jörg Spiekerkötter commented: 'The
Supervisory Board thanks Dr Wenninger for his many years of commitment and
support as well as his enormous contribution to the success and growth of
the company', and added: 'I am very pleased that we could win Dr Stock as
an industry expert as a new Supervisory Board member for PAION AG. I look
forward to working together.'
###
About Dr Harald F. Stock
Dr Harald F. Stock studied Chemistry and Business Administration in the
USA, Great Britain and Germany and received a PhD in inorganic chemistry
from University of Heidelberg in 1997. He started his career in healthcare
as a key account manager at Hestia Pharma. Thereafter he held various
positions of increasing responsibilities in local and global functions and
corporate divisions of the Roche Group, until in 2005 he was appointed
Senior Vice President of the global Near Patient Testing sector in Graz.
From 2006 until end of 2008 he was Chairman and Managing Director of the
German DePuy Group, the Orthopaedics Division of Johnson&Johnson. Between
April and December 2008, he in addition represented Johnson&Johnson on the
Board of BVMed, the German Medical Technology Industry Association. In
January 2009 he was appointed Chief Executive Officer of the Grünenthal
Group based in Aachen. Harald F. Stock also has been a Board Observer on
the Board of Directors of ConforMIS, Inc., Burlington, MA, USA since 2009
and was appointed Member of the Board for immatics biotechnologies GmbH,
Tübingen, Germany, in February 2011.
About PAION
PAION is a biopharmaceutical company headquartered in Aachen, Germany and
has a second site in Cambridge, UK. The company is specialized in
developing and commercializing innovative drugs for the hospital-based
treatment in indications for which there is a substantial unmet medical
need. PAION has a 'Search&Develop' business model, which is based on its
core expertise in drug development. Where appropriate, particularly during
the late stages of the clinical development, PAION seeks to collaborate
with experienced partners.
Contact
Ralf Penner
Director Investor Relations / Public Relations
PAION AG
Martinstrasse 10-12, 52062 Aachen - Germany
Phone +49 241 4453-152
E-mailr.penner(at)paion.com
http://www.paion.com
Disclaimer:
This release contains certain forward-looking statements concerning the
future business of PAION AG. These forward-looking statements contained
herein are based on the current expectations, estimates and projections of
PAION AG's management as of the date of this release. They are subject to a
number of assumptions and involve known and unknown risks, uncertainties
and other factors. Should actual conditions differ from the Company's
assumptions, actual results and actions may differ materially from any
future results and developments expressed or implied by such
forward-looking statements. Considering the risks, uncertainties and other
factors involved, recipients should not rely unreasonably upon these
forward-looking statements. PAION AG has no obligation to periodically
update any such forward-looking statements to reflect future events or
developments.
End of Corporate News
---------------------------------------------------------------------
24.05.2011 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: PAION AG
Martinstr. 10-12
52062 Aachen
Deutschland
Phone: +49 (0)241-4453-0
Fax: +49 (0)241-4453-100
E-mail: info(at)paion.com
Internet: www.paion.com
ISIN: DE000A0B65S3
WKN: A0B65S
Listed: Regulierter Markt in Frankfurt (Prime Standard);
Freiverkehr in Berlin, Düsseldorf, Hamburg, München,
Stuttgart
End of News DGAP News-Service
---------------------------------------------------------------------
125985 24.05.2011
Datum: 24.05.2011 - 15:29 Uhr
Sprache: Deutsch
News-ID 34190
Anzahl Zeichen: 0
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 333 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: PAION AG: ANNUAL GENERAL MEETING ELECTS DR HARALD F. STOCK TO THE SUPERVISORY BOARD"
steht unter der journalistisch-redaktionellen Verantwortung von
PAION AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
